Clinical Trials
2 trialsNCT00064012 2019-12-13
Bortezomib With or Without Docetaxel in Treating Patients With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer
University of Wisconsin, Madison
Phase 2 Completed
NCT00068289 2013-06-24
Bortezomib in Treating Patients With Recurrent or Refractory Extensive-Stage Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy
National Cancer Institute (NCI)
Phase 2 Completed